NCT05693896

Brief Summary

More than 30% of Black women with obesity binge eat. Binge eating may increase the risk for the development of metabolic syndrome and binge-eating-disorder (BED), which is associated with severe obesity. Though several effective treatments for binge eating exist, Black women have not fared well. Not only has their inclusion in treatment trials been limited, but when participating, they are more likely to drop out, and/or lose less weight, compared to their White counterparts. Furthermore, treatment for binge eating is often not available in primary care and community-based settings places where Black women are more likely to receive treatment for their eating and weight-related concerns. Currently, there is scant intervention research to treat binge eating in Black women. With the highest rates of obesity (57%) nationally, Black women are in need of culturally-relevant treatments for binge eating and weight gain prevention. Given the established relationship between frequent binge eating and subsequent weight gain, addressing binge eating among Black women with obesity is imperative.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
7mo left

Started Jan 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Jan 2025Dec 2026

First Submitted

Initial submission to the registry

January 11, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

January 23, 2023

Completed
2 years until next milestone

Study Start

First participant enrolled

January 15, 2025

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Last Updated

August 27, 2025

Status Verified

July 1, 2025

Enrollment Period

1.9 years

First QC Date

January 11, 2023

Last Update Submit

August 20, 2025

Conditions

Outcome Measures

Primary Outcomes (3)

  • Feasibility (Recruitment): Total Number of Eligible Adults Enrolled in the Study

    Recruitment is defined as the number of potential eligible adults screened for the study versus the number of persons who enrolled in the study.

    3 month

  • Retention: Percentage of Participants Retained in the Study

    Percentage of eligible participants who were enrolled and retained in the study through the 6 months.

    6 months

  • Attendance: Percentage of Intervention Sessions Attended

    Percentage of intervention sessions attended for the duration of the study by each participant.

    6 months

Secondary Outcomes (4)

  • Change from Baseline to Month 3 in weight regain

    Baseline, 3 months

  • Change from Baseline to Month 6 in weight regain

    Baseline, 6 months

  • Change in number of Binge Eating Episodes from Baseline to Month 3

    Baseline, 3 months

  • Change in number of Binge Eating Episodes from Baseline to Month 6

    Baseline, 6 months

Study Arms (2)

Centering Appetite Intervention, Then Attention- Control Group

EXPERIMENTAL

Participants randomized to the attention-control group will participate remotely via a smartphone app and online lessons. The intervention will build participants' self-efficacy to reduce binge eating and to assist them in preventing weight gain.

Behavioral: Centering Appetite

Attention- Control Group, Then Centering Appetite Intervention

NO INTERVENTION

Participants randomized to the centering appetite intervention group will receive weekly psychoeducation emails about general wellness topics, discussion of binge eating, diet, and physical activity.

Interventions

A digital treatment of Appetite Awareness Treatment (AAT) and behavioral weight loss treatment (BWL) over 6 months, delivered remotely using Zoom. The goal of AAT is to enable participants to be able to relearn their stomach's hunger signals and begin to obey and monitor functions of satiety. AAT has been successful in helping participants diagnosed with Binge Eating Disorder (BED) and bulimia nervosa reduce binge eating, overeating, urges to eat in response to non-appetite stimuli, and prevent weight gain.

Centering Appetite Intervention, Then Attention- Control Group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Over 18 years of age,
  • BMI ≥ 30 kg/m\^2,
  • have and regularly use a Bluetooth-enabled smartphone,
  • report at least one binge eating episode weekly,
  • work or live within 30 miles of Kannapolis, NC,
  • complete the screening questionnaire

You may not qualify if:

  • currently pregnant,
  • in substance abuse treatment,
  • involved in another weight reduction program,
  • have a history of anorexia,
  • are purging,
  • currently in treatment for eating difficulties,
  • are concurrent intravenous drug users
  • consume \>4 alcoholic beverages/day

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UNC-Chapel Hill

Chapel Hill, North Carolina, 27599, United States

RECRUITING

MeSH Terms

Conditions

BulimiaBinge-Eating DisorderObesity

Condition Hierarchy (Ancestors)

HyperphagiaSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding and Eating DisordersMental DisordersOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody Weight

Study Officials

  • Rachel Goode, PhD,MPH

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Tyisha Harper, MBA

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 11, 2023

First Posted

January 23, 2023

Study Start

January 15, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 27, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share

Locations